Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
483
•Barclay, Luke, & Pillai Specialty Pharmacy, PLLC•December 14, 2018

Barclay, Luke, & Pillai Specialty Pharmacy, PLLC – FDA 483, Dec 14, 2018

Record Details

The FDA Form 483 details numerous deficiencies at a facility producing purportedly sterile drug products, including injectables and pellets.

Key violations include: - **Sterility Assurance:** Procedures for preventing microbiological contamination are not established or followed. The ISO 5 laminar flow hood certification lacked documentation of dynamic condition simulation and airflow visualization. Media fill challenge tests were not conducted every six months as required. - **Sterilization Validation:** The firm did not include biological indicators in sterilization loads for drug products, and sterilization parameters for Stanozolol 50 mg/mL were not validated. - **Environmental Control:** Environmental and personnel monitoring during sterile drug production is not performed. Cleanroom, anteroom, and ISO 5 laminar flow hood certifications were not performed annually. A HEPA filter was absent over an area where sterile product was exposed. - **Aseptic Processing & Personnel:** Pellets purportedly sterile are produced in a non-sterile, negative pressure, unclassified room. Cleaning and disinfecting systems for aseptic areas are deficient, using non-sterile wipes and mop heads. Personnel clothing was inappropriate, with exposed skin observed around goggles during production. - **Quality Control & Testing:** Discrepancies in biological indicator test results were not investigated. Glassware used for non-sterile bulk drug substances was not depyrogenated. Hold times for cleaned, uncovered glassware were not determined. Stability programs are inadequate, lacking sterility testing at end of shelf life. Sterility, endotoxin

Company
Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
Inspection date
December 14, 2018
Office
San Francisco District Office
Person
  • Uttaniti Limchumroon
View Company Profile

ID · 325a2d3f-e024-4cd5-bc11-31c21774153b

Violation Codes2
21 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
  • 483 - 2022-12-09December 9, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.